Embracing the Change: China Commercial Health Insurance Opportunities

Commercial health insurance (CHI) has an increasingly important role to play in China’s healthcare security system.

Why Consumers are Leaving your Website, and What to do About it

Apparel and footwear companies still have a long way to go to improve conversions.

Commercial Creativity for Industrials: Monetize to Make an Immediate Impact

For the past decade, technology and industrials companies have viewed digital through an “efficiency” lens.

True Profit! No Company Ever Went Broke Turning a Profit

Embracing the Change: Accessing Rare Disease Patients in China

Chinese rare diseases environments are dynamic and rapidly changing, and a number of new access and affordability options are emerging for innovative therapies.

A Day in the Life of Consultant Lillian in Beijing

Lillian Li, Consultant in our Beijing office, joined Simon-Kucher two years ago.

What Will Be the Impact of the New IPT Consolidation Plan on P&MA in Spain?

In December 2020, the Spanish MoH presented a plan to consolidate Therapeutic Positioning Reports (IPTs) with an aim to formally incorporate health-economic evaluations into these reports (e.g. cost-effectiveness).

Mitigating NHI Price Erosion in Japan

Post-launch NHI price recalculation in Japan can feel unavoidable.

Changes in the Mexican Healthcare System: Striving to Increase Public Access for High-Cost Drugs

In this article we explore the ongoing changes and implications for manufacturers interested in gaining and keeping access in the public setting in Mexico.

Large Deal Negotiations: How to Win When the Power of Innovation Levels Off

Life cycle theory says that all industries will inevitably reach the maturity stage: a phase of slow growth and stagnation in markets previously driven by innovation and high growth dynamics.